In bladder cancer, METTL3 interacts with DGCR8, and actively promotes the maturation of pri-miR-221/222 in a m6A dependent manner, further reduces the expression of PTEN and promotes the proliferation of bladder cancer [42]. The gene discussed is METTL3; the disease is urinary bladder cancer.